|
ARNT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.00239999318342E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.83729999495108E-08 |
| Normal-vs-Stage2 |
2.95100000002879E-06 |
| Normal-vs-Stage3 |
4.49259999979468E-07 |
| Normal-vs-Stage4 |
2.30399999999742E-05 |
| Stage1-vs-Stage2 |
5.901400E-01 |
| Stage1-vs-Stage3 |
8.139600E-01 |
| Stage1-vs-Stage4 |
9.494800E-01 |
| Stage2-vs-Stage3 |
7.482800E-01 |
| Stage2-vs-Stage4 |
6.367200E-01 |
| Stage3-vs-Stage4 |
8.298200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.02920005430019E-09 |
| Normal-vs-AfricanAmerican |
4.852200E-02 |
| Normal-vs-Asian |
1.369740E-04 |
| Caucasian-vs-AfricanAmerican |
9.622500E-02 |
| Caucasian-vs-Asian |
3.874400E-01 |
| AfricanAmerican-vs-Asian |
3.719400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71100000001534E-06 |
| Normal-vs-Female |
4.88130003084564E-09 |
| Male-vs-Female |
6.483000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.18680000049665E-07 |
| Normal-vs-Age(41-60Yrs) |
4.64560000468239E-08 |
| Normal-vs-Age(61-80Yrs) |
1.71001000000004E-05 |
| Normal-vs-Age(81-100Yrs) |
1.177360E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.120600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.071800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.747600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.318400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.941200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.608800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.610200E-02 |
| Classical-VS-Follicular |
6.212800E-04 |
| Classical-VS-Other |
8.398200E-01 |
| Classical-VS-Normal |
2.20500000003288E-06 |
| Tall-VS-Follicular |
4.575600E-01 |
| Tall-VS-Other |
6.515200E-01 |
| Tall-VS-Normal |
2.53849999998224E-06 |
| Follicular-VS-Other |
3.956800E-01 |
| Follicular-VS-Normal |
4.08909994753515E-09 |
| Other-VS-Normal |
5.401700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08490003039685E-09 |
| Normal-vs-N1 |
9.32860000024682E-07 |
| N0-vs-N1 |
8.914800E-01 |
|
|
